X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.98 | -26,668 | 134,459 | -17% | -$52,690 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Barton Russell | COO | S - Sale | $1.97 | -9,318 | 126,799 | -7% | -$18,325 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Siemers Eric | Chief Medical Officer | S - Sale | $1.96 | -10,834 | 159,464 | -6% | -$21,277 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.98 | -47,506 | 619,982 | -7% | -$94,176 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Officer | S - Sale | $1.97 | -14,905 | 216,839 | -6% | -$29,436 | |||||
| M | 2026-01-07 | ABOS | Acumen Pharmaceuticals, Inc. | Doherty James J. | Pres, CDO | S - Sale | $1.85 | -8,167 | 54,033 | -13% | -$15,148 | |||||
| M | 2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.77 | -26,472 | 593,510 | -4% | -$46,954 | |||||
| M | 2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.80 | -50,659 | 83,800 | -38% | -$91,073 | |||||
2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Officer | S - Sale | $1.82 | -6,888 | 209,951 | -3% | -$12,513 | ||||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.83 | -12,035 | 881,275 | -1% | -$21,993 | |||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.87 | -8,934 | 173,999 | -5% | -$16,721 | |||||
| DM | 2026-01-26 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale+OE | $3.00 | -17,756 | 173,999 | -9% | -$53,280 | |||||
2026-01-14 | ACRE | Ares Commercial Real Estate Corp | Feingold Anton | Gen. Counsel VP, Secretary | S - Sale | $4.93 | -7,606 | 92,754 | -8% | -$37,479 | ||||||
2026-01-14 | ACRE | Ares Commercial Real Estate Corp | Gonzales Jeffrey Michael | CFO, Treasurer | S - Sale | $4.93 | -6,218 | 88,533 | -7% | -$30,640 | ||||||
2026-01-14 | ACRE | Ares Commercial Real Estate Corp | Donohoe Bryan Patrick | CEO | S - Sale | $4.93 | -21,761 | 250,197 | -8% | -$107,230 | ||||||
| D | 2026-01-07 | AERG | Applied Energetics, Inc. | Adamczyk Bradford Thomas | Dir | S - Sale+OE | $1.77 | -10,000 | 2,245,081 | 0% | -$17,700 | |||||
| D | 2026-01-20 | AERG | Applied Energetics, Inc. | McCahon Stephen William | Chief Science Officer | S - Sale+OE | $1.80 | -10,000 | 12,772,861 | 0% | -$18,000 | |||||
| D | 2026-01-21 | AERG | Applied Energetics, Inc. | Quarles Gregory James | CEO Emeritus | S - Sale+OE | $1.87 | -6,600 | 0 | -100% | -$12,342 | |||||
| D | 2026-01-26 | AERG | Applied Energetics, Inc. | Donaghey Christopher Wayne | Pres, CEO, Principal AO | S - Sale+OE | $1.65 | -10,000 | 133,592 | -7% | -$16,500 | |||||
2026-01-28 | AIMD | Ainos, Inc. | Taiwan Carbon Nano Technology Corp | 10% | S - Sale | $2.17 | -46,000 | 989,925 | -4% | -$99,806 | ||||||
2026-01-20 | AIRG | Airgain Inc | Elbaz Michael | CFO | S - Sale | $4.00 | -4,587 | 133,106 | -3% | -$18,330 | ||||||
2026-01-20 | AIRG | Airgain Inc | Sadri Ali | CTO | S - Sale | $4.00 | -4,733 | 127,030 | -4% | -$18,914 | ||||||
2026-01-20 | AIRG | Airgain Inc | Suen Jacob | Pres, CEO | S - Sale | $4.00 | -15,993 | 293,635 | -5% | -$63,908 | ||||||
2026-01-16 | AKAN | Akanda Corp. | Hrt Financial LP | 10% | S - Sale | $1.29 | -7,868 | 7,816 | -50% | -$10,150 | ||||||
2026-01-21 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale | $1.56 | -26,269 | 616,866 | -4% | -$40,980 | ||||||
| M | 2026-01-05 | ANTX | An2 Therapeutics, Inc. | Eizen Joshua M | See Remarks | S - Sale | $1.00 | -24,854 | 152,499 | -14% | -$24,962 | |||||
2025-12-29 | APHP | American Picture House Corp | Macgregor Bannor Michael | CEO, 10% | S - Sale | $0.13 | -1,768,555 | 21,636,048 | -8% | -$232,830 | ||||||
2026-01-20 | AURA | Aura Biosciences, Inc. | De Los Pinos Elisabet | See Remarks | S - Sale | $4.86 | -16,928 | 585,226 | -3% | -$82,270 | ||||||
| D | 2026-01-06 | BB | Blackberry Ltd | Giamatteo John Joseph | CEO, Pres, Secure Comm. | S - Sale+OE | $3.88 | -87,723 | 859,840 | -9% | -$340,365 | |||||
2026-01-05 | BFLY | Butterfly Network, Inc. | Ku Victor | CTO | S - Sale | $3.82 | -35,968 | 811,962 | -4% | -$137,398 | ||||||
| M | 2026-01-06 | BFLY | Butterfly Network, Inc. | Rothberg Jonathan M | Dir, 10% | S - Sale | $4.12 | -1,140,180 | 30,033,885 | -4% | -$4,695,583 | |||||
2026-01-07 | BFLY | Butterfly Network, Inc. | Doherty John N. | EVP, CFO | S - Sale | $3.98 | -60,182 | 1,234,688 | -5% | -$239,524 | ||||||
2026-01-15 | BLND | Blend Labs, Inc. | Kneafsey Brian | Head of Revenue | S - Sale | $3.06 | -25,000 | 649,824 | -4% | -$76,420 | ||||||
2026-01-16 | CCCC | C4 Therapeutics, Inc. | Reyno Leonard | Chief Medical Officer | S - Sale | $2.22 | -10,000 | 156,382 | -6% | -$22,200 | ||||||
| M | 2026-01-16 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.97 | -32,474 | 617,824 | -5% | -$161,520 | |||||
| M | 2026-01-26 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.98 | -19,274 | 580,329 | -3% | -$96,045 | |||||
| M | 2026-01-29 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.23 | -24,770 | 555,559 | -4% | -$104,862 | |||||
2026-01-20 | CLOV | Clover Health Investments, Corp. /De | Reynoso Jamie L. | CEO, Medicare Advantage | S - Sale | $2.58 | -4,597 | 2,737,700 | 0% | -$11,860 | ||||||
| M | 2026-01-05 | CRCT | Cricut, Inc. | Ashish Arora | CEO, 10% | S - Sale | $4.91 | -62,499 | 4,177,922 | -1% | -$306,764 | |||||
2026-01-06 | CREX | Creative Realities, Inc. | Slipstream Communications, LLC | 10% | S - Sale | $2.52 | -1,425,485 | 0 | -100% | -$3,592,222 | ||||||
| M | 2026-01-06 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.85 | -50,000 | 50,000 | -50% | -$42,500 | |||||
| M | 2026-01-13 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.87 | -50,000 | 200,000 | -20% | -$43,250 | |||||
| M | 2026-01-20 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.84 | -50,000 | 150,000 | -25% | -$42,000 | |||||
| M | 2026-01-27 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.84 | -50,000 | 100,000 | -33% | -$42,000 | |||||
| D | 2026-01-02 | DGXX | Digi Power X Inc. | Amar Alec | Pres | S - Sale+OE | $2.72 | -27,500 | 1,335,616 | -2% | -$74,800 | |||||
2026-01-21 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Pres, DTR Division | S - Sale | $4.00 | -24,996 | 1,433,054 | -2% | -$99,984 | ||||||
| D | 2026-01-21 | DTIL | Precision Biosciences Inc | Kelly John Alexander | CFO | S - Sale+OE | $4.03 | -15,213 | 106,448 | -13% | -$61,308 | |||||
| D | 2026-01-21 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $4.03 | -10,200 | 118,115 | -8% | -$41,106 | |||||
| D | 2026-01-22 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $4.17 | -34,799 | 196,154 | -15% | -$145,112 | |||||
| D | 2026-01-21 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $4.03 | -8,854 | 44,715 | -17% | -$35,682 | |||||
| M | 2026-01-06 | DVLT | Datavault Ai Inc. | Scilex Holding Co | 10% | S - Sale | $1.24 | -14,713,490 | 229,731,770 | -6% | -$18,176,455 | |||||
| M | 2026-01-12 | DVLT | Datavault Ai Inc. | Scilex Holding Co | 10% | S - Sale | $0.83 | -15,965,541 | 213,766,229 | -7% | -$13,215,896 | |||||
2026-01-07 | EU | Encore Energy Corp. | Sheriff William M | See Remarks | S - Sale | $2.81 | -10,000 | 2,240,931 | 0% | -$28,100 | ||||||
| DM | 2025-12-30 | EXFY | Expensify, Inc. | Alvarez Divo Carlos Eduardo | Dir | S - Sale+OE | $1.51 | -8,972 | 285,508 | -3% | -$13,507 | |||||
2026-01-09 | FATE | Fate Therapeutics Inc | Tahl Cindy | See Remarks | S - Sale | $1.06 | -10,589 | 387,081 | -3% | -$11,275 | ||||||
| M | 2026-01-05 | HOWL | Werewolf Therapeutics, Inc. | Evnin Luke | Dir | S - Sale | $0.65 | -71,054 | 2,401,243 | -3% | -$45,882 | |||||
| M | 2026-01-08 | HOWL | Werewolf Therapeutics, Inc. | Evnin Luke | Dir | S - Sale | $0.59 | -91,374 | 2,309,869 | -4% | -$53,533 | |||||
| M | 2026-01-13 | HOWL | Werewolf Therapeutics, Inc. | Evnin Luke | Dir | S - Sale | $0.56 | -111,227 | 2,198,642 | -5% | -$61,787 | |||||
2026-01-16 | HOWL | Werewolf Therapeutics, Inc. | Evnin Luke | Dir | S - Sale | $0.54 | -38,782 | 2,159,860 | -2% | -$20,942 | ||||||
2026-01-05 | IRWD | Ironwood Pharmaceuticals Inc | Silver Ronald | Principal Accounting Officer | S - Sale | $4.60 | -35,416 | 276,809 | -11% | -$162,914 | ||||||
| M | 2026-01-06 | IVFH | Innovative Food Holdings Inc | Bennett Robert William | Former CEO and Director | S - Sale | $0.33 | -2,114,440 | 377,571 | -85% | -$703,364 | |||||
| M | 2026-01-14 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $2.31 | -6,325 | 832,209 | -1% | -$14,599 | |||||
| M | 2026-01-14 | LDI | Loandepot, Inc. | Hsieh Anthony Li | Exec Chair, CEO, Pres, 10% | S - Sale | $2.68 | -1,300,000 | 168,283 | -89% | -$3,487,784 | |||||
| E | 2026-01-07 | LLY | Eli Lilly & Co | Lilly Endowment Inc | 10% | S - Sale | $0.11 | -292,148 | 91,896,978 | 0% | -$33,045 | |||||
2026-01-16 | LPSN | Liveperson Inc | Mina Christopher Allen | Chief Tech Product Officer | S - Sale | $3.15 | -7,152 | 52,636 | -12% | -$22,543 | ||||||
| D | 2025-12-31 | LWLG | Lightwave Logic, Inc. | El-Ahmadi Siraj Nour | Dir | S - Sale+OE | $3.15 | -49,260 | 99,535 | -33% | -$155,218 | |||||
| D | 2026-01-27 | LWLG | Lightwave Logic, Inc. | El-Ahmadi Siraj Nour | Dir | S - Sale+OE | $3.48 | -25,591 | 123,944 | -17% | -$89,057 | |||||
| M | 2026-01-23 | MDBH | Mdb Capital Holdings, LLC | James Jeremy William | CFO | S - Sale | $3.32 | -3,500 | 19,839 | -15% | -$11,621 | |||||
| M | 2026-01-07 | MIST | Milestone Pharmaceuticals Inc. | Oliveto Joseph | Pres, CEO | S - Sale | $2.25 | -43,500 | 303,721 | -13% | -$97,875 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Bharucha David | Chief Medical Officer | S - Sale+OE | $2.25 | -70,252 | 113,181 | -38% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Nelson Jeffrey Edward | COO | S - Sale+OE | $2.25 | -70,252 | 49,848 | -58% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Muller Lorenz | Chief Commercial Officer | S - Sale+OE | $2.25 | -64,746 | 205,406 | -24% | -$145,851 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Hasija Amit | CFO, EVP of Corp. Development | S - Sale+OE | $2.25 | -70,252 | 99,848 | -41% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Oliveto Joseph | Pres, CEO | S - Sale+OE | $2.24 | -167,577 | 482,744 | -26% | -$375,315 | |||||
| D | 2026-01-05 | MOBX | Mobix Labs, Inc | Samini Keyvan | Pres, CFO, Dir | S - Sale+OE | $0.32 | -211,672 | 2,989,865 | -7% | -$68,645 | |||||
2026-01-15 | MQ | Marqeta, Inc. | Cummings Martha | Dir | S - Sale | $4.41 | -2,853 | 41,822 | -6% | -$12,589 | ||||||
2026-01-15 | MQ | Marqeta, Inc. | Sumner Crystal | See Remarks | S - Sale | $4.41 | -5,055 | 317,004 | -2% | -$22,312 | ||||||
2025-12-31 | MVST | Microvast Holdings, Inc. | Pan Yixin | Dir | S - Sale | $2.76 | -12,596 | 130,739 | -9% | -$34,778 | ||||||
2026-01-15 | NKTX | Nkarta, Inc. | Mahmood Nadir | Pres | S - Sale | $2.07 | -5,649 | 167,727 | -3% | -$11,693 | ||||||
2026-01-15 | NKTX | Nkarta, Inc. | Hastings Paul J | CEO | S - Sale | $2.07 | -26,046 | 390,023 | -6% | -$53,915 | ||||||
| M | 2026-01-14 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.64 | -500,000 | 1,550,000 | -24% | -$1,322,285 | |||||
| M | 2026-01-14 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.64 | -500,000 | 1,550,000 | -24% | -$1,322,285 | |||||
| M | 2026-01-26 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.37 | -295,220 | 1,254,780 | -19% | -$699,926 | |||||
| M | 2026-01-26 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.37 | -295,220 | 1,254,780 | -19% | -$699,926 | |||||
2026-01-29 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
2026-01-29 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
2026-01-16 | NRDY | Nerdy Inc. | Paszterko John Andrew | COO | S - Sale | $1.01 | -18,457 | 581,543 | -3% | -$18,642 | ||||||
| M | 2026-01-15 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $1.62 | -61,194 | 1,139,177 | -5% | -$99,331 | |||||
| D | 2026-01-16 | NXDR | Nextdoor Holdings, Inc. | Schwartz Sophia | GC, Secretary | S - Sale+OE | $1.95 | -23,278 | 286,587 | -8% | -$45,299 | |||||
| D | 2026-01-16 | NXDR | Nextdoor Holdings, Inc. | How Antoinette | Chief Accounting Officer | S - Sale+OE | $1.95 | -13,935 | 18,270 | -43% | -$27,124 | |||||
2025-11-21 | NXXT | Nextnrg, Inc. | Leibler Jack | Dir | S - Sale | $1.03 | -150,000 | 56,007 | -73% | -$154,485 | ||||||
| DM | 2026-01-05 | ODYS | Odysight.Ai Inc. | Y.D. More Investments Ltd | 10% | S - Sale+OE | $3.33 | -324,093 | 1,004,593 | -24% | -$1,079,184 | |||||
2026-01-20 | PLRX | Pliant Therapeutics, Inc. | Coulie Bernard | Pres, CEO | S - Sale | $1.28 | -89,375 | 914,918 | -9% | -$114,400 | ||||||
2026-01-20 | PLRX | Pliant Therapeutics, Inc. | Cummings Keith Lamont | CFO | S - Sale | $1.28 | -24,002 | 297,214 | -7% | -$30,723 | ||||||
2026-01-12 | PLUG | Plug Power Inc | Haycraft Benjamin | CSO, GM EMEA | S - Sale | $2.17 | -40,000 | 333,809 | -11% | -$86,800 | ||||||
| M | 2026-01-26 | RIG | Transocean Ltd. | Adamson Keelan | Pres, CEO | S - Sale | $5.00 | -81,533 | 1,222,182 | -6% | -$407,665 | |||||
| M | 2026-01-26 | RIG | Transocean Ltd. | Long Brady K | EVP, GC | S - Sale | $5.00 | -115,378 | 1,046,031 | -10% | -$576,890 | |||||
2026-01-08 | RMNI | Rimini Street, Inc. | Perica Michael L. | EVP, CFO | S - Sale | $4.00 | -53,882 | 92,150 | -37% | -$215,528 | ||||||
| D | 2026-01-05 | RXRX | Recursion Pharmaceuticals, Inc. | Gibson Christopher | Dir | S - Sale+OE | $4.25 | -40,000 | 913,839 | -4% | -$170,000 | |||||
2026-01-06 | RXRX | Recursion Pharmaceuticals, Inc. | Borgeson Blake | Dir | S - Sale | $4.36 | -220,000 | 6,649,863 | -3% | -$959,200 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |